コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 high risk for DVT (eg, recent total knee or hip arthroplasty).
2 rthroplasty and 2298 of whom underwent total hip arthroplasty.
3 urgical fixation, hemiarthroplasty, or total hip arthroplasty.
4 oarthritis and the subsequent need for total hip arthroplasty.
5 e pain management after total knee and total hip arthroplasty.
6 0-day readmission, mortality, and conversion hip arthroplasty.
7 ell as motor function of patients with total hip arthroplasty.
8 non-diabetic postmenopausal women undergoing hip arthroplasty.
9 l pain management after total knee and total hip arthroplasty.
10 ed following knee arthroplasty compared with hip arthroplasty.
11 roplasty and 0.26% (95% CI, 0.14%-0.37%) for hip arthroplasty.
12 roplasty and 0.14% (95% CI, 0.07%-0.21%) for hip arthroplasty.
13 sty and 348,596 who underwent revision total hip arthroplasty.
14 ht-sided hip pain, before and 9 months after hip arthroplasty.
15 tomatic events, in patients undergoing total hip arthroplasty.
16 ury, as well as patients undergoing elective hip arthroplasty.
17 nidine was used in patients undergoing total hip arthroplasty.
18 s between minimal and standard incisions for hip arthroplasty.
19 ity and morbidity following elective knee or hip arthroplasty.
20 between ethnic groups are not seen following hip arthroplasty.
21 R 1.22, 95% CI 0.63-2.36 in Hispanics) after hip arthroplasty.
22 omboembolism within three months after total hip arthroplasty.
23 patients who had previously undergone total hip arthroplasty.
24 EA (-1.6%; 95% CI, -2.9% to -0.3%; P = .02), hip arthroplasty (-0.8%; 95% CI, -1.0% to -0.5%; P < .00
25 in both groups were cholecystectomy (10.5%), hip arthroplasty (10.5%), spine surgery (9.8%), herniorr
26 grafting and widened for 3 procedures, total hip arthroplasty (11.6 per 100 000 persons in males, 20.
27 2 (1-2) days, 10 948 (37.4%) underwent total hip arthroplasty, 18 316 (62.6%) underwent total knee ar
28 e groups of patients: 14 who were undergoing hip arthroplasty, 28 hemodialysis patients who were part
29 G: -0.7% [95% CI, -0.1% to -0.5%; P < .001]; hip arthroplasty: -3.0% [95% CI, -3.6% to -2.3%; P < .00
30 -$3253; 95% CI, -$3879 to -$2627; P < .001), hip arthroplasty (-$328; 95% CI, -$634 to -$21; P = .04)
31 exceeded the valuation time including total hip arthroplasty (5% longer) and total knee arthroplasty
34 inform decisions about surgical approach for hip arthroplasty, although further research is needed to
38 increased from 1.0 to 2.0 for primary total hip arthroplasty and 1.1 to 2.3 for revision (P < .001).
39 (14.3% among the patients assigned to total hip arthroplasty and 13.1% among those assigned to hemia
40 s enoxaparin (40 mg daily) for 35 days after hip arthroplasty and 14 days after knee arthroplasty pro
41 rred in 34 patients (4.7%) assigned to total hip arthroplasty and 17 patients (2.4%) assigned to hemi
42 A beneficiaries who underwent primary total hip arthroplasty and 348,596 who underwent revision tota
43 s (7.9%) who were randomly assigned to total hip arthroplasty and 60 of 723 patients (8.3%) who were
44 these thalamic volume changes reverse after hip arthroplasty and are associated with decreased pain
45 f venous thromboembolism is high after total hip arthroplasty and could persist after hospital discha
46 ed in 300 patients (41.8%) assigned to total hip arthroplasty and in 265 patients (36.7%) assigned to
49 who were randomly assigned to undergo total hip arthroplasty and those who were assigned to undergo
50 zation (range: 61% for TURP to 88% for total hip arthroplasty), and are thus missed by the ProPublica
51 artery bypass grafting (CABG), 19% in Total Hip Arthroplasty, and 18% in Total Knee Arthroplasty.
52 ndergoing knee arthroplasty, 1850 undergoing hip arthroplasty, and 30 undergoing shoulder arthroplast
55 eripheral bypass, pulmonary lobectomy, total hip arthroplasty, and total knee arthroplasty between 20
56 e or hip radiographic OA, without total knee/hip arthroplasty, and without frequent knee/hip pain wer
57 Short stem, uncemented femoral implants for hip arthroplasty are bone conserving achieving stability
59 e edema, and intramuscular edema after total hip arthroplasty at 1.5-T MRI with metal artifact reduct
60 re not who underwent elective total knee and hip arthroplasty at a single urban academic institution.
62 ficiaries who underwent primary and revision hip arthroplasty between 1991 and 2008, there was a decr
67 16, through November 30, 2018: total knee or hip arthroplasty, coronary artery bypass grafting, colec
69 ons are commonly used in patients with total hip arthroplasty despite a lack of established efficacy.
70 have been used in dental implants and total hip arthroplasty due to their excellent biocompatibility
71 were having elective inpatient total knee or hip arthroplasty, either primary or revision, and had a
72 infection (SSI) is a feared complication in hip arthroplasty, especially following femoral neck frac
76 new radiographic finding of hip OA or total hip arthroplasty for OA (OR 1.71, 95% CI 1.16-2.52, P =
79 om 74.1 to 75.1 years and for revision total hip arthroplasty from 75.8 to 77.3 years (P < .001).
81 nagement approach after total knee and total hip arthroplasty has increasingly become an alternative.
83 ary artery bypass grafting, colectomy, total hip arthroplasty, hip fracture repair, and lumbar spine
84 was borderline statistically significant for hip arthroplasty (HR 0.73 [95% CI 0.52-1.03], P = 0.07),
87 diographs across 313 patients and included 4 hip arthroplasty implants from 4 leading implant manufac
88 vel deep learning-based approach to identify hip arthroplasty implants' design using anterior-posteri
89 ectomy, thoracic surgery, and total knee and hip arthroplasty in a single-center prospective observat
90 an age for patients undergoing primary total hip arthroplasty increased from 74.1 to 75.1 years and f
93 ment after total knee arthroplasty and total hip arthroplasty is pivotal, as it determines the outcom
94 moral hernia repair, mastectomy, lumpectomy, hip arthroplasty, knee arthroplasty, hysterectomy, spina
97 mptomatic venous thromboembolism after total hip arthroplasty most commonly develops after the patien
102 rthroplasty and 6,703 patients who underwent hip arthroplasty over a 5-year period were analyzed.
105 a pedicle screw cervical spine fixation and hip arthroplasty performed on a porcine and ovine cadave
107 a large EHR of veterans who had 45 351 total hip arthroplasty procedures in Veterans Health Administr
109 igned to undergo hemiarthroplasty, and total hip arthroplasty provided a clinically unimportant impro
111 me allograft bone donated from primary total hip arthroplasty recipients must be discarded or treated
116 aged 18 to 90 years undergoing total knee or hip arthroplasty; spine surgery; coronary artery bypass
117 ith durable FICS undergoing definitive total hip arthroplasty surgery because of local tumor progress
118 which they performed anterior approach total hip arthroplasty surgery on a high-fidelity model with r
119 a low of 0.005 for "Procedure-Targeted Total Hip Arthroplasty Surgical Site Infection." Generally, re
126 rrowing in the contralateral hip after total hip arthroplasty (THA) for osteoarthritis (OA) and the f
128 that included 556 patients undergoing total hip arthroplasty (THA) from December 2015 to October 201
129 irty-day readmission to hospital after total hip arthroplasty (THA) has significant direct costs and
130 ferent types of polyethylene liners in total hip arthroplasty (THA) in terms of wear penetration (mm/
132 Femoral component subsidence following total hip arthroplasty (THA) is a worrisome radiographic findi
135 at the modular head-neck interface in total hip arthroplasty (THA) is predominately expressed in the
136 tal of 108 men and women scheduled for total hip arthroplasty (THA) or total knee arthroplasty (TKA)
137 boembolism (VTE) prophylaxis following total hip arthroplasty (THA) or total knee arthroplasty (TKA).
138 hospitals' SSI rates following primary total hip arthroplasty (THA) or total knee arthroplasty (TKA).
139 lation (RFA) and dislocation following total hip arthroplasty (THA) remain poorly understood, highlig
140 utcomes in patients who have undergone total hip arthroplasty (THA) with a fully hydroxyapatite coate
141 V using direct anterior approach (DAA) total hip arthroplasty (THA), and very little is known on its
142 e implant hemiarthroplasty (HA) versus total hip arthroplasty (THA), cemented versus non cemented fem
151 The study included cases with primary total hip arthroplasties (THAs) and primary total knee arthrop
152 In muscle of patients who were undergoing hip arthroplasty, the 14-kD actin fragment level was cor
154 tion, coronary artery bypass grafting, total hip arthroplasty, total knee arthroplasty, and heart val
155 air, abdominal aortic aneurysm repair, total hip arthroplasty, total knee arthroplasty, and lung rese
156 throplasty (TPKA) and after total or partial hip arthroplasty (TPHA) are proposed patient safety indi
157 w option in multimodal analgesia after total hip arthroplasty.Trial registration: Chinese Clinical Tr
158 rquartile range [IQR], 17-48 days) following hip arthroplasty vs 42 days (IQR, 21-114 days) following
159 on postoperative outcomes in total knee and hip arthroplasty, we retrospectively compared postoperat
162 patients scheduled to undergo elective total hip arthroplasty were randomly assigned, stratified acco
164 reviewed in a cohort of 58 patients with 66 hip arthroplasties with Rejuvenate stems who had present
165 llowing knee arthroplasty and 0.7% following hip arthroplasty, with no significant differences by rac